fbpx
Medical Innovation Exchange

Trial site staff shortages, sluggish patient recruitment force Addex to scrap phase 3 Parkinson’s study

https://www.fiercebiotech.com/biotech/addex-blindsides-investors-scrapping-phase-3-parkinsons-study-over-slow-covid-impacted

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.